OmniAb Inc

Research OmniAb Inc (OABI) on Bullrun: market cap USD 372.58M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerOABI
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 372.58M
• Financial periodFY2025
• RevenueUSD 18.67M
• Revenue growth-29.3%
• Net income-USD 64.78M
• Free cash flow-USD 37.02M

Valuation Snapshot

latest market cap is USD 372.58M.

About OmniAb Inc

OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts.

Frequently asked questions

What is OmniAb Inc's market cap?

OmniAb Inc's market capitalization is USD 372.58M.

What does OmniAb Inc do?

OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.